Topic
5 articles on longevity-treatments in longevity medicine. View all news →
A buyer guide to IV NAD+, IV NR, oral NR and NMN that separates biochemical effects from unproven longevity outcomes and checks sterile-compounding risks.
IV nutrient therapy can be clinically useful for selected deficiencies, but anti-aging claims are weaker. Here is how to compare clinics, costs, and safety protocols.
A company announcement planned Niagen IV availability at more than 80 OneSpaWorld medi-spas. It confirms a commercial rollout, not clinical benefit, onboard availability, or superior safety.
Therapeutic plasma exchange is established for selected diseases, not for extending healthy lifespan. A 42-person trial changed epigenetic clocks, but did not test fewer diseases, better function, or longer life.
BBC reporting shows a market ranging from ordinary prevention to expensive tests and experimental treatments. This guide separates documented offers from proven health benefit.
